Profile
Corporate information
Investment activity status
Active investor
Overview
Abionic is a scale-up specializing in nanotechnology for diagnostic tests. It has developed biosensors that allow to detect sepsis on a drop of blood in 5 minutes. Current methods take 24 to 72 hours. The early detection of sepsis, a condition that develops as a result of a bacterial infection, saves lives. Every year, 11 million people die because of septic shock.
Funding
Funding rounds
Change in valuation: unknown
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Verve Capital Partners AG | Switzerland | Initial investment. Round participant. |
Change in valuation: unknown
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Zurich Cantonal Bank | Switzerland | Initial investment. Round participant. |
Cap Table
Current and past shareholders
| Investor | Round | |
|---|---|---|
|
|
Verve Capital Partners AG |
N/A |
|
|
Zurich Cantonal Bank |
N/A |